Evaluating : Actualité Evaluating en direct - P1 | Bourse Reflex
Accueil > Tags > Evaluating

  • Toutes les actualités en rapport avec « Evaluating »

29/03 18:00 Evaluating - Quantum Genomics publishes its financial results for the year 2017

15/02 07:00 Evaluating - ECA Group - Petrus: Significant Partnership and Positioning in Subsea Robotics Services (AUVs and ROV) for the Oil and Gas Market

15/02 07:00 Evaluating - ECA Group - Petrus: Significant Partnership and Positioning in Subsea Robotics Services (AUVs and ROV) for the Oil and Gas Market

08/03 18:00 Evaluating - Agreement for the exchange of intellectual property between MVG and ETS-Lindgren

28/02 08:30 Evaluating - GENTICEL ANNOUNCES ITS 2016 ANNUAL RESULTS

30/01 18:00 Evaluating - BUSINESS UPDATE - FOURTH QUARTER 2016

22/12 13:00 Evaluating - Genticel and Genkyotex Announce Intention to Enter into Strategic Combination

16/12 14:30 Evaluating - Naturex is rewarded for the quality of its Investor Relations in the area of Sustainable Development

30/11 08:00 Evaluating - GENTICEL successfully completes determining milestone in partnership with Serum Institute regarding use of GTL003 in multivalent vaccines

27/10 18:35 Evaluating - BUSINESS UPDATE - THIRD QUARTER 2016

29/09 17:45 Evaluating - Quantum Genomics reports positive top-line results from Phase IIa trial of QGC001 in hypertension

28/07 18:35 Evaluating - BUSINESS UPDATE - SECOND QUARTER 2016

06/07 18:35 Evaluating - GENTICEL APPOINTS EUMEDIX AS STRATEGIC ADVISOR TO SUPPORT COMPANY'S ACCESS TO INNOVATIVE DRUG CANDIDATES

14/03 07:00 Evaluating - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

27/01 18:40 Evaluating - GENTICEL REPORTS INITIAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

25/01 18:00 Evaluating - BUSINESS UPDATE - FOURTH QUARTER 2015

07/01 07:30 Evaluating - GENTICEL TO EVALUATE ROCHE MOLECULAR SYSTEMS' COBAS(R) HPV TEST IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

05/01 19:00 Evaluating - Genticel appoints Rémi Palmantier, PhD, as Chief Scientific Officer to accelerate its development

03/11 10:15 Evaluating - MEDTECH ANNOUNCES USD 15 MILLION NOTE FINANCING

29/10 18:00 Evaluating - Genticel Announces First Patient Treated in U.S. Phase 1 Clinical Trial of GTL001, Company's Therapeutic Vaccine Candidate against HPV 16/18 Infections